LEV Pharmaceuticals Inc. (LEVP.OB) Stock Soars after ViroPharma $443 Million Offer
Timing is everything in the business world. Timing in the pharmaceutical business world is even more critical. Very little can be happening in the world of pharmaceuticals when, all of a sudden everybody is interested in a company’s work and time-to-market status. An investor who can see the timing in pharmaceutical product development will find profit arriving quickly and abundantly. LEV Pharmaceuticals Inc., a development stage biopharmaceuticals company, works to develop and commercialize biopharmaceuticals directed at inflammation and heart attack. The company’s primary work is related to the C1INH protein - which causes a genetically debilitating inflammation of certain areas…